Avecia

Milford, United States Founded: 1999 • Age: 27 yrs Acquired By Nitto
CDMO specializing in oligonucleotide production and complex small molecule synthesis
Request Access

About Avecia

Avecia is a company based in Milford (United States) founded in 1999 was acquired by Nitto in February 2011.. Avecia offers products and services including Preclinical Manufacturing, Analytical Development, Process Development, and Drug Substance Manufacturing. Avecia operates in a competitive market with competitors including RiboBio, Liberate Bio, Shanghai Rui Platinum Biotechnology, Genedesign and Lerna Biopharma, among others.

  • Headquarter Milford, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Nitto Avecia
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $3.9 M (USD), Grant

    Jun 12, 2006

  • Investors
    Nitto

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Nitto

    (Feb 03, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Avecia

Avecia offers a comprehensive portfolio of products and services, including Preclinical Manufacturing, Analytical Development, Process Development, and Drug Substance Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides custom solutions for preclinical oligonucleotide production.

Develops and validates methods for raw materials and final products.

Creates safe and cost-effective processes for oligonucleotide programs.

Offers complete manufacturing solutions with extensive experience.

People of Avecia
Headcount 500-1000
Employee Profiles 97
Employee Profiles
People
Edvikol Proko
Quality Control Analyst II
People
Eric Hemmingsen
Sr Project Manager
People
Michael Beauchamp
Research Scientist III
People
Marie Laliberte
Senior Compliance Specialist

Unlock access to complete

Funding Insights of Avecia

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $3.9M
  • First Round

    (12 Jun 2006)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2006 Amount Grant - Avecia Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Avecia

Avecia has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Nitto and USAGov. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entity focused on information and services
Founded Year Domain Location
Diversified materials are manufactured and supplied for various industries.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Avecia

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Avecia

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Avecia Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Avecia

Avecia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RiboBio, Liberate Bio, Shanghai Rui Platinum Biotechnology, Genedesign and Lerna Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of oligonucleotides
domain founded_year HQ Location
Contract manufacturing for tissue-specific nucleic acid therapeutics is provided.
domain founded_year HQ Location
Provider of drug research and development services
domain founded_year HQ Location
Nucleic acid development and manufacturing services are provided.
domain founded_year HQ Location
Develops nucleic acid therapeutics using chemistry and biological insights for effective treatments.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Avecia

Frequently Asked Questions about Avecia

When was Avecia founded?

Avecia was founded in 1999 and raised its 1st funding round 7 years after it was founded.

Where is Avecia located?

Avecia is headquartered in Milford, United States.

What does Avecia do?

Avecia was founded in 1999 in Milford, United States, and operates as a biotechnology firm serving as a contract development and manufacturing organization. Services are provided for oligonucleotide drug substances, including antisense RNA, siRNA, miRNA, aptamers, conjugates, and immunostimulatory types. Capabilities encompass backbone, base, sugar modifications, linkers, post-synthesis conjugates, and terminal phosphates. Complex small molecule synthesis is also handled. The company was acquired by Nitto Denko, a Japanese materials manufacturer.

Who are the top competitors of Avecia?

Avecia's top competitors include Shandong Sanyuan Biotechnology, RiboBio and Liberate Bio.

What products or services does Avecia offer?

Avecia offers Preclinical Manufacturing, Analytical Development, Process Development, and Drug Substance Manufacturing.

Who are Avecia's investors?

Avecia has 2 investors. Key investors include Nitto, and USAGov.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available